Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study

OBJECTIVE: Metformin reduces cancer incidence and improves overall survival in diabetic patients. In preclinical studies, metformin decreases endometrial cancer (EC) cell growth by activation of AMPK/mTOR inhibition. We sought to determine the effects of metformin on serum/tumor biomarkers in women...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gynecol Oncol
Autors principals: Soliman, Pamela T., Zhang, Qian, Broaddus, Russell R., Westin, Shannon N., Iglesias, David, Munsell, Mark F., Schmandt, Rosemarie, Yates, Melinda, Ramondetta, Lois, Lu, Karen H.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116402/
https://ncbi.nlm.nih.gov/pubmed/27745917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2016.10.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars